Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 19/20 | 0.45 |
| ▸ | CA2 | P00918 | 19/20 | 0.45 |
| ▸ | CA4 | P22748 | 9/20 | 0.45 |
| ▸ | CA12 | O43570 | 4/20 | 0.45 |
| ▸ | CA9 | Q16790 | 4/20 | 0.45 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15161172 | 0.87 | CA1 (0.48) | CA1CA2CA4CA12CA9 | |
| SCHEMBL15159292 | 0.86 | CA1 (0.42) | CA1CA2CA4CA12CA9 | |
| SCHEMBL17365333 | 0.85 | CA1 (0.52) | CA1CA2CA4CA12CA9 | |
| SCHEMBL14367687 | 0.80 | TERT (0.48) | CA1CA2CA4CA12CA9 | |
| SCHEMBL12983642 | 0.77 | CA1 (0.42) | CA1CA2CA4CA12CA9 | |
| SCHEMBL13027061 | 0.75 | CA1 (0.42) | CA1CA2CA4CA12CA9 | |
| SCHEMBL13273544 | 0.75 | CA1 (0.46) | CA1CA2CA4CA12CA9 | |
| SCHEMBL17897072 | 0.74 | CA1 (0.36) | CA1CA2CA4CA12CA9 | |
| SCHEMBL10001927 | 0.69 | TERT (0.40) | CA1CA2CA4CA12CA9 | |
| SCHEMBL19234764 | 0.69 | TERT (0.43) | CA1CA2CA4CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9732378-B2 | Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-08-15 | — | — | US | disclosed |
| US-20160194690-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-07-07 | — | — | US | disclosed |
| US-9221759-B2 | Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2015-12-29 | — | — | US | disclosed |
| US-20130202536-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2013-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130202536-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | CLTA, LARS1, SSB | CA1 335/4885CA2 385/4885CA4 139/4885 |
| US-20160194690-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | CLTA, LARS1, SSB | CA1 335/4885CA2 385/4885CA4 139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.